Related Experiment Video

Updated: Jul 6, 2025

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.0K

Necroptosis Stimulates Interferon-Mediated Protective Anti-Tumor Immunity

Francis Chan1, A Justin Rucker2, Christa Park3

  • 1Liangzhu Laboratory, Zhejiang University.

Research Square
|January 10, 2024
PubMed

Insights

Immunizing with necroptotic (programmed necrosis) cells, dependent on Receptor Interacting Protein Kinase 3 (RIPK3), provides superior tumor protection. This immunity relies on CD4+ T cells and type I interferon signaling, not inflammation.

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Necroptosis, a form of programmed necrosis, is RIPK3-dependent and implicated in anti-tumor immunity.
  • Distinguishing necroptosis's role from apoptosis and inflammation in anti-tumor responses is challenging.
  • Previous studies suggest necroptotic cell immunization protects against tumors, but the mechanisms are unclear.

Approach:

  • Developed a system to selectively induce RIPK3-dependent necroptosis or apoptosis with minimal inflammation.
  • Utilized a syngeneic tumor challenge model to assess protection conferred by necroptotic cell immunization.
  • Investigated the roles of CD4+ T cells, CD8+ T cells, and type I interferon signaling in the observed anti-tumor immunity.

Key Points:

  • Immunization with necroptotic cells offered superior protection against tumor challenge compared to other cell death modalities.
  • The protective anti-tumor immunity was dependent on CD4+ T cells, not CD8+ T cells.
  • Host type I interferon signaling was crucial for the observed protective effect.

Conclusions:

  • RIPK3-dependent necroptosis, independent of significant NF-κB-driven inflammation, can elicit potent anti-tumor immunity.
  • Death-associated type I interferon production following necroptosis is sufficient to induce protective anti-tumor immune responses.
  • This study highlights necroptosis as a promising strategy for cancer immunotherapy by leveraging DAMPs release and interferon signaling.

More Related Videos

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells09:15

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells

Published on: October 20, 2022

2.2K
Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

8.6K

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
789
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
921
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.7K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.8K